Loading clinical trials...
Loading clinical trials...
A 24-week Open-label Clinical Trial to Assess Tolerability and Antihypertensive Effect and in Hemodynamic Parameters and Arterial Stiffness of Fimasartan 60 mg Plus Amlodipine Besylate 5 mg Given Once a Day in Patients With Hypertension in Stadiums 2/3
Conditions
Interventions
Fimasartan plus amlodipine besylate
Start Date
September 1, 2017
Primary Completion Date
March 1, 2018
Completion Date
August 1, 2018
Last Updated
September 26, 2017
NCT06649110
NCT07218029
NCT06481852
NCT01347216
NCT05464095
NCT06954727
Lead Sponsor
Centro Universitario de Ciencias de la Salud, Mexico
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions